06/08/2026
When we talk about prostate cancer treatment, we usually ask one question:
"Will it treat the cancer?"
That's exactly where the conversation should start.
But perhaps it shouldn't be where it ends.
The recently published 10-year UK study has strengthened the evidence that, for many suitable men with localised prostate cancer, focal therapy can provide excellent long-term cancer control while significantly reducing life-changing side effects. (info here: https://www.imperial.nhs.uk/about-us/news/new-study-shows-focal-therapy-treats-prostate-cancer)
So here's another question...
What if choosing the right treatment for the right patient could also help the NHS?
Imagine:
💙Shorter hospital stays.
💙More day-case procedures.
💙Less costly at the point of delivery
💙Fewer treatment-related complications.
💙Less aftercare costs (incontinence/sexual support)
💙More efficient use of NHS resources.
This isn't about one treatment replacing another.
Surgery, radiotherapy, active surveillance and focal therapy all have an important place in prostate cancer care. The key is ensuring that every suitable man understands all of his treatment options so ‘he’ can make a truly informed decision.
Because informed choices don't just benefit patients.
They have the potential to benefit the NHS too.
The evidence has moved on. Its time to catch up...